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ABSTRACT 
 
Cognitive research with human non-smokers has demonstrated that nicotine generally 
enhances performance on tasks of attention but, working memory does not appear to be affected.  
In contrast, nicotine has been shown to produce robust enhancements of working memory in 
non-human animals. To address this disparity, the present study investigated the effects of 
nicotine (2mg, 4mg nicotine gum, and placebo) on the performance of 30 non-smokers (15 male) 
completing a working memory task developed for rodents (the odor span task, OST). Nicotine 
has been reported to enhance OST performance in rodents and the present study sought to 
determine whether the effect is generalizable to human performance. In addition to completing 
the OST, participants completed a cognitive battery of clinical and experimental tasks assessing 
working memory and attention. This allowed for a direct comparison of OST performance to 
other commonly used measures of human cognition. Findings showed that nicotine was 
associated with dose dependent enhancements in sustained attention, as evidenced by increased 
hit accuracy on the rapid visual information processing (RVIP) task. However, nicotine failed to 
produce main effects on OST performance or on alternative measures of working memory (digit 
span, spatial span, letter-number sequencing, 2-back) or attention (digits forward, 0-back). 
Interestingly, enhancement of RVIP performance occurred concomitant to significant reductions 
in self-reported attention/concentration. Human OST performance was significantly related to N-
back performance and, as in rodents, OST accuracy declined with increasing memory load. 
Given the similarity of human and rodent OST performance and the strong association observed 
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between OST and visual 0-back accuracy, the OST may be particular useful for preclinical 
studies of conditions characterized by inattention.
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INTRODUCTION 
 
  The health impact of tobacco smoking is staggering, causing over 5 million deaths per 
year world-wide and accounting for nearly $100 billion in healthcare costs each year in the US 
alone (CDC; 2002, 2008). While national prevention and cessation efforts have succeeded in 
reducing the prevalence of smoking in the US over recent years, more than a fifth of the adult 
population continues to smoke (SAMHSA, 2013) despite quit attempts reported by 52.4% of 
adult smokers each year (CDC, 2011).  Improving the effectiveness of prevention and cessation 
efforts relies on a thorough understanding of the reinforcing properties of smoking.  Motivations 
for smoking behavior are diverse and likely evolve across the transition from adoption to 
dependent smoking.  For example, prior to nicotine exposure, initiation of smoking is likely 
dependent on learned associations between smoking and desired outcomes and attributes (Baker, 
Brandon, & Chassin, 2004).  After initiation however, smoking behavior may be reinforced by 
the direct pharmacological action of constituents in tobacco smoke as well as by alleviation of 
the withdrawal syndrome that can occur after discontinuation of extended use.  Alterations in 
cognitive processing after acute exposure to nicotine, the primary psychoactive constituent in 
tobacco smoke, has been proposed as a mechanism through which smoking is reinforced in some 
individuals (Evans & Drobes, 2009). However, the effects of nicotine on cognitive processing in 
humans remain ill refined.   
The relationship between cognition and nicotine dependence in humans is most clearly 
evidenced by the impairments that occur during the course of nicotine withdrawal.  Difficulty 
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concentrating is a frequently reported symptom of nicotine withdrawal (Hughes, Higgins, & 
Bickel, 1994) and significant impairments in attention as assessed by the rapid visual information 
processing task (RVIP) can be observed within 30 minutes of nicotine deprivation (Hendricks, 
Ditre, Drobes, & Brandon, 2006).  Furthermore, administration of nicotine during withdrawal 
has been shown to normalize sensory abilities, motor abilities, selective attention, divided 
attention, sustained attention, and certain forms of memory (Heishman, Taylor, & Henningfield, 
1994).   Similarly, nicotine has been shown to improve cognitive functioning in individuals 
diagnosed with disorders characterized by cognitive deficits (e.g., schizophrenia and attention 
deficit hyperactivity disorder; Dalack, Healy, & Meador-Woodruff, 1998).   
Cognitive enhancement may explain the high prevalence of smoking observed for 
individuals diagnosed with these conditions (approximately three fold that of the general 
population).  In addition to reinforcing continued smoking in nicotine dependent individuals and 
in those with pronounced cognitive deficits, nicotine may serve to facilitate the adoption of 
regular smoking behavior in non-dependent individuals through cognitive enhancement.  It has 
been reported that nicotine can enhance cognitive abilities in non-smokers (Heishman et al., 
1994) and the accumulation of evidence over the past decade has made it possible to conduct a 
meta-analysis these effects. 
Acute Effects of Nicotine 
Across 41 studies on the effects of nicotine on non-smokers, non-deprived smokers, and 
minimally deprived smokers (less than 2 hours), Heishman, Kleykamp, and Singleton (2010)  
have reported significant enhancements in fine motor ability (finger tapping, handwriting and 
pegboard tasks), sustained attention/alerting attention accuracy and reaction time (e.g. RVIP and 
continuous performance task; CPT), orienting attention reaction time (e.g. target detection and 
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letter search), short-term episodic memory (e.g. word recall and word recognition), and working 
memory reaction time (e.g. N-back and digit recall tasks).  Significant effects were not found for 
orienting attention accuracy (e.g. target detection and letter search), long-term episodic memory 
accuracy (e.g. word recall and recognition), or working memory accuracy (e.g. N-back and digit 
recall tasks).  That this profile of acute nicotine effects does not include enhancements in 
working memory accuracy appears to conflict with studies conducted in non-human mammals 
that have demonstrated robust enhancements in working memory performance after 
administration of nicotine and selective nicotinic agonists (Levin, McClernon, & Rezvani, 2006).  
Most notably, nicotine has been shown to enhance delayed match to sample (DMTS) 
performance in monkeys (Buccafusco, Beach, & Terry, 2009), and radial arm maze performance 
in rodents (Levin, Bradley, Addy, & Sigurani, 2002; Levin, Briggs, Christopher, & Rose, 1992; 
Levin, Icenogle, & Farzad, 2005; Levin, Kim, & Meray, 1996; Levin & Torry, 1996).   
The discrepancy between animal and human findings may represent a species difference 
in nicotine effects, methodological differences in the doses tested, or a disparity between the 
behavioral tasks used to assess the construct of working memory.  If there is indeed a prominent 
species difference in nicotine effects on cognitive processing, thorough characterization of the 
behavioral and neurobiological discrepancies will need to be addressed if animal models are to 
inform human cognition.  Cross-species methodological issues could be attenuated through the 
development and use of translational behavioral tasks, thereby allowing for more sensitive 
comparisons of dose effects. Additionally, such tasks would provide a framework for testing 
cognition across species and bridge definitional gaps in theories of cognition. 
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Assessing Working Memory in Animals and Humans 
Animal models of working memory are designed to assess processes analogous to those 
identified in human subjects.  Towards this end, procedures such as delayed match-to-sample 
(DMTS) and delayed non-match-to-sample (DNMTS) tasks have been used with a variety of 
species to demonstrate patterns of forgetting (loss of stimulus control) across delays that are 
comparable to patterns observed in humans (Wright, 2007).  Variants of DMTS/DNMTS 
procedures, along with tasks such as the radial arm maze and the within-session Morris swim 
task, have been used specifically as models of working memory (for a review see Dudchenko, 
2004).  Operational definitions of working memory procedures for non-humans typically require 
that stimulus information only be presented during a single learning trial and only be useful for 
controlling behavior during a single trial or session (Bannerman, Rawlins, & Good, 2006; 
Dudchenko, 2004; Olton, Becker, & Handelmann, 1979).  For example, in match and non-
match-to-sample tasks (MTS, NMTS), an animal is presented with a sample stimulus (e.g. a 
green light) and is subsequently presented with the sample stimulus (a green light) concurrently 
with a comparison stimulus (a red light).  In a MTS task, only responses to the sample stimulus 
(the green light) are reinforced while in a NMTS task only responses to the comparison stimulus 
(the red light) are reinforced.  Thus, in a given trial of either task, the subject must remember the 
stimulus initially presented to provide an accurate response when presented with a choice.  
Subjects are tested across many trials in which the sample stimulus is alternated.  Thus, the 
stimulus information presented during each trial only informs accurate responding during that 
same trial.  
Radial arm maze tasks are also used to assess this form of one trial learning.  In this task, 
rodents are placed in the center of an open field apparatus that has a number of arms extending 
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from a central platform.  Each of these arms is baited with a food reward and the rat is able to 
explore the apparatus and consume the rewards.  Any time the subject re-enters an arm which it 
has already explored an error is scored.  In optimal performance of the task the rat enters each 
arm only once.  During a session (referred to as a trial in some designs), the subject must 
remember which arms it has visited; errors are interpreted as a failure of memory.  The subject 
can be tested repeatedly as memory for arm entry is only useful for performance during the 
testing session (though in certain testing arrangements response strategies can develop across 
sessions).   
In humans, working memory is currently described in terms of short term memory stores 
of limited capacity that require controlled attention (Baddeley, 2003; Saults & Cowan, 2007).  
Though the capacity limits of working memory in humans have been disputed (Baddeley, 2003; 
Cowan, 2001), assessment of capacity is the primary way in which working memory is assessed 
clinically.  The Weschler Adult Intelligence Scale (WAIS-III) and the Weschler Memory Scale 
(WMS-III) both include several tasks assessing working memory capacity (Psychological 
Corporation, 2002).   These subscales include digit span (DS), spatial span (SS), letter-number 
sequencing (LNS) and arithmetic.  All but the arithmetic subscale, can be considered “span 
tasks” in which individuals provide a recall of strings of stimuli (letters, numbers, or spatial 
positions).  Simple span tasks require the individual to report the string of stimuli in the order it 
was presented (DS forward, SS forward) while complex span tasks require the individual to 
reorder the stimulus string (DS Backward, SS Backward, and LNS).  Deficits selective to 
complex but not simple span tasks are inferred to result from impairments of working memory 
apart from more general impairments of attention.  
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The use of capacity tasks have been critical to the shaping of current theories of cognition 
(Richardson, 2007).  In turn, theory has led to the development of novel working memory 
assessments such as the N-back task.  Like span tasks, the N-back task requires individuals to 
remember strings of stimuli of varying lengths.  Stimuli are presented sequentially and 
individuals must respond to each presentation with a response indicating whether the stimulus 
matches the stimulus which was presented 1, 2, or 3 positions backs (referred to as the 1-back, 2-
back, or 3-back tasks).  There is also a 0-back task in which individuals simply indicate if each 
stimulus matches a target stimulus which is identified at the beginning of testing.  The 0-back 
task can be considered a more general assessment of attention.  While the N-back task is 
conceptually similar to span tasks, measures derived from the N-back fail to correlate or 
correlate weakly with typical span measures suggesting the N-back may capture a unique facet of 
working memory (Hill et al., 2009; Kane, Conway, Miura, & Colflesh, 2007; Miller, Price, 
Okun, Montijo, & Bowers, 2009).   
Translational Working Memory Tasks 
While both human and non-human working memory tasks assess forms of one-trial 
learning, there is a dearth of procedures available for studying short-term memory capacity in 
rodents.  As such, it is difficult to infer how deficits or enhancements in MTS/NMTS or radial 
arm maze performance map onto the capacity sensitive measures used in humans.  A notable 
exception is the olfactory span task (OST) for rodents (Dudchenko, Wood, & Eichenbaum, 2000) 
which incorporates manipulations of memory load into a single-session learning paradigm.  In 
trial 1 of the procedure, rats are presented with a single olfactory stimulus (a cup of scented sand) 
in an arena.  Responses to this stimulus (digging) are reinforced through the retrieval of a food 
reward buried within the scented sand. On trial 2, a second stimulus cup scented with a different 
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odor is baited with a food reward and placed in a random position in the arena along with the 
stimulus presented during the first trial (not baited). The rat is free to respond to either of the 
scented stimuli present, but only responses to the novel odor produce a food reward. On the third 
trial, the two previously presented odors are moved to new positions and a third odor is 
introduced. Once again, only responses to the novel odor are reinforced.  
The procedure is continued in this fashion with the introduction of a novel odor on each 
trial until up to 24 stimuli are present. Thus the procedure can be viewed as a non-match-to-
sample task in which each stimulus serves as a sample during its initial presentation and as a 
comparison stimulus in each additional trial. The task might be best described as an incrementing 
non-match-to-sample task as the number of stimuli that can serve as comparisons increases on 
each successive trial.  Performance on the OST is measured in overall accuracy and span during 
each session.  Dudchenko and colleagues found that the span lengths produced by individual rats 
varied greatly across testing days, but that the average median span of subjects was relatively 
consistent (M=8.38 ±.49).  More importantly, average percent correct performance across 
sessions at each span length of the procedure decreased significantly as span increased showing 
an inverse relationship between accuracy and the number of stimuli to be remembered (memory 
load).   
In recent work with the OST in rats, several controls have been implemented that 
enhance the interpretation of OST performance and make the task more suitable for  
pharmacological investigations (MacQueen, Bullard, & Galizio, 2011).  In the original design of 
the OST, the capacity manipulation (number of odors to remember) is inherently confounded 
with the number of choices presented, such that decreased accuracy at increasing span lengths 
could be inferred to represent the effect of increasing comparisons.  By limiting stimulus 
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presentation to a maximum of 5 odors on each trial (the novel sample and four comparison odors 
chosen randomly from the set of odors previously presented), chance performance is equated at 
20% for each trial beyond the fourth.  Use of this procedural adaptation has demonstrated that in 
rats, reductions in accuracy relate to the number of stimuli to remember even when the number 
of comparisons presented is held constant (MacQueen et al., 2011).  Additionally, a control task 
(a repeated olfactory simple discrimination task) was implemented within-session to detect 
changes in motivation and olfactory discrimination during performance of the span task.  Use of 
this control allowed for the detection of drug-induced deficits that were selective only to odor 
span accuracy (sparing performance control accuracy). 
  The OST has demonstrated considerable promise for investigating the neurobiological 
determinants of memory capacity and is sensitive to cholinergic manipulations. In rats, 
performance of the odor span task is transiently disrupted by lesioning of the basal forebrain 
cholinergic system (Turchi & Sarter, 2000).  The procedure has also been successfully adapted 
for testing mice (Young, Kerr, et al., 2007) and performance decrements have been observed in 
α7 nicotinic cholinergic receptor knockout (Young, Crawford, et al., 2007) and in human 
amyloid over-expressing mice (Young, Sharkey, & Finlayson, 2009).  Notably, direct facilitation 
of OST performance after administration of nicotinic agonists has been recently reported in rats 
(Rushforth et al. 2010).  Taken together, these findings suggest that nicotinic receptors play an 
integral role in OST performance in non-human animals, and suggest that nicotine administration 
enhances performance.  
Importantly, the odor span task has been adapted for use with humans (Levy, et al., 
2003). Thus, the OST exemplifies the type of translational behavioral task that can be used to 
assess short term memory capacity in both humans and non-human animals. By using identical 
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procedures this paradigm mitigates methodological and operationalization issues, thus allowing 
for cross-species comparisons of dose-response effects. Such tasks allow for stronger inferences 
to be drawn from animal models. 
To clarify what cognitive processes are augmented by nicotine and to arrive at a better 
understanding of the neurocognitive processes assessed by the OST, the present study sought to 
evaluate the effects of nicotine on a human adaptation of the OST as well as well-validated 
clinical and experimental tasks of attention and working memory.  To avoid the confounds 
associated with distinguishing withdrawal reversal from a more general enhancement of 
cognition, only non-smokers with a limited history of nicotine exposure were recruited.  Prior 
studies investigating the effects of nicotine on attention and memory in non-smokers and ex-
smokers suggested that nicotine was most likely to enhance accuracy on sustained attention (also 
described as alerting attention) tasks and reaction time on tasks of sustained attention/alerting 
attention, and working memory.  Thus, it was expected that nicotine would produce robust 
enhancement of accuracy on a task of sustained attention (RVIP), limited enhancement of 
accuracy on the attention related components of clinical working memory tasks (Digit Span 
forward, Spatial Span forward, 0-back accuracy), enhacement of reaction time on experimental 
sustained attention and working memory tasks (RVIP, 0-back and 2-back), while producing no 
effects on the accuracy of working memory performance derived from clinical or experimental 
tasks (Digit Span backward or total, Spatial Span backward or total, Letter-number Sequencing, 
and 2-back accuracy).   
The present study sought to expand upon prior findings with non-smokers by testing 
participants on a modified version of the OST which incorporated novel control procedures 
described in preclinical investigations.  The primary aim of including the OST was to validate 
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the task in humans and determine if the nicotine facilitation of OST performance evidenced in 
rats generalizes to human performance. Validation of the OST occured through several methods. 
First, the human OST procedure previously reported by Levy et al. (2003) was modified such 
that chance performance and capacity were not confounded. This allowed for an assessment of 
the effects of capacity on human OST accuracy and a comparison with the effects observed in 
rodents. The modified version also included a performance control component designed to assess  
motivation to respond accurately and the reliability of odor discrimination during performance of 
the task. Given the novelty of the OST, a primary goal was to examine convergent and divergent 
validity of the OST with well validated tasks of attention and working memory.   
Though the OST has been most frequently described as a working memory task 
(Dudchenko et al., 2000; Young, Kerr, et al., 2007), it has been suggested that OST performance 
deficits may actually represent attentional deficits (Young, Crawford, et al., 2007).  Thus, we 
expected odor span measures to demonstrate convergent validity with the accuracy measures of 
attention related tasks such as RVIP, 0-back, and the forward components of clinical working 
memory tasks.  In contrast, we did not expect odor span measures to be significantly related to 
accuracy on complex working memory tasks such as 2-back accuracy, Letter-number 
sequencing, or the backward and total measures of clinical span tasks.  As a control measure, we 
expected that simple odor discrimination would show divergent validity with odor span 
performance and all measures of attention or working memory.    
Given the substantial preclinical data implicating involvement of the cholinergic system 
in OST perfromance (Rushforth, Allison, Wonnacott, & Shoaib, 2010; Rushforth, Steckler, & 
Shoaib, 2011; Turchi & Sarter, 2000; Young, Crawford, et al., 2007; Young, Kerr, et al., 2007), 
it was expected that nicotine would enhance OST performance amongst human non-smokers as 
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has been observed in rats (Rushforth et al., 2010).  Demonstrating consistent pharmacological 
effects across species and determining neurocognitive correlates of human OST performance 
represent critical steps in realizing the translational utility of the OST. 
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METHODS 
 
Experimental Design 
 Participants completed 3 experimental sessions over the course of three weeks with each 
session scheduled to start within 2 hours of the start time used for each participant’s other 
sessions.  During each experimental session participants received 2mg, or 4mg nicotine gum or a 
placebo gum.  Dose order was counterbalanced across participants in this double-blind placebo 
controlled within-subjects design. Dependent measures included cognitive task performance and 
self-report measures of cognition. 
Participants 
 Power analyses (Cohen, 1988) suggested that 28 participants would be necessary to 
achieve a power level of .80 in detecting a significant medium sized effect (f = .25) within 
subjects at an α level of .05.  Based upon the test-retest reliability of the clinical working 
memory measures included in the study (.71-.83) the correlation of repeated measures was 
assumed to be approximately .75.  Because the nicotine manipulation was expected to affect the 
performance of some individuals more than others, we predicted the correlation of measures to 
be somewhat lower in our study.  As such, a correlation of measures estimate of .50 was used to 
calculate power. To ensure sensitivity and to provide complete counterbalancing of dose order 
across participants, recruitment continued until 30 participants completed all three experimental 
sessions.  Participants between the ages of 18 and 54 were recruited from the Tampa area 
through internet, newspaper and radio advertisements as well as through the Tobacco Research 
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and Intervention Program (TRIP) participant database.  Participants received an initial screening 
over the telephone.  Those who appeared to meet inclusion criteria were informed that the study 
involved one assessment/screening session and three experimental sessions for which they would 
be compensated at a rate of $20/hr. and a bonus of $20 at the end of the final session.   
Individuals who appeared eligible and interested in study participation during the phone 
screening were scheduled for an assessment session.  During the assessment session, informed 
consent was obtained and subjects were evaluated through standardized interviews, 
questionnaires, and biochemical analysis to ensure the inclusion criteria were met.  
Inclusion/Exclusion Criteria 
Participants were screened to ensure they were between the ages of 18 and 54 and able to 
read and understand the consent form and questionnaires.  Participants were required to be non-
smokers who reported no more than 5 occasions of nicotine product use (e.g., cigarettes, cigars, 
chewing tobacco) during their lifetime with no use of nicotine products within the past year.  
Recent smoking and drinking was determined from analysis of breath samples collected at the 
beginning of each assessment and experimental session.  Any participant providing a breath 
sample with a carbon monoxide level of greater than 3ppm at any point was excluded from the 
study.  This cutoff has been shown to identify those who have smoked within the past day with 
71.5% sensitivity and 84.8% specificity (Javors, Hatch, & Lamb, 2005).  Any participant 
submitting a breath sample with a detectable alcohol content was not allowed to participate in the 
scheduled experimental session but permitted to reschedule.  Any participant who submitted two 
alcohol positive breath samples was excluded from the study.  Any evidence of recent illicit 
substance use identified by urinalysis also resulted in study exclusion.  
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Participants were also  excluded if they had any history of heart disease, high blood 
pressure, any blood circulation disorder, phenylketonuria, asthma, food allergies, other serious 
medical condition (e.g. cancer, kidney disease) as well as any dental conditions that would 
prohibit gum chewing.  Participants were screened for psychiatric illness by an advanced clinical 
psychology doctoral student, utilizing the Structured Clinical Interview for DSM-IV (First, 
Spitzer, Gibbon, & Williams, 1994).  Participants meeting criteria for a current mood or 
psychotic disorder, substance dependence or panic disorder were also excluded.  For female 
participants, pregnancy was assessed through urinalysis and participants who were currently 
pregnant or expected that they could become pregnant during the course of the study were 
excluded.   
Procedures 
 Assessment Session 
At the start of the assessment session participants were greeted by a member of the 
research team who described the study in detail and responded to questions.  Potential 
participants were informed of the potential risks, benefits, purpose, compensation associated with 
participation and their HIPAA privacy rights before consent was sought.  Research staff 
presented the consent document verbally and allowed the participant to review the consent 
materials before administering a written consent form quiz to the participant.  Both the consent 
form and the associated quiz were written at a sixth grade level and the experimenter provided 
clarification as necessary.   
The consent quiz was composed of 5 multiple choice questions on the material covered in 
the consent form.  If a participant failed to answer a question correctly, they were directed to re-
read the section of the consent form containing the relevant information and answer again.  No 
15 
 
participant failed to answer any question on the quiz correctly on the second attempt.  As several 
of the measures used in the proposed study have only been developed in English, our sample was 
limited to English speaking participants.  Those demonstrating an adequate understanding of 
consent materials were given the opportunity to consent.  Participants were informed that their 
participation was voluntary and could be withdrawn at any time.  After signing the consent form, 
participants received a copy of the consent document (including HIPAA authorization) for their 
personal records.   
After the consent procedure, the participants submitted two breath samples for the 
purpose of estimating carbon monoxide and breath alcohol content.  A urine test was 
administered to test for drug use.  It was possible to detect cannabis usage within 14 to 30 days, 
tricyclic antidepressants usage within 10 days, barbiturate and PCP usage 3 to 8 days, 
benzodiazepine usage within 2 to 14 days, amphetamine/methamphetamine usage within 2 to 6 
days, and cocaine/opiate usage within 2 to 5 days.  Urine samples submitted by women were 
additionally tested for pregnancy. Participants were excluded for pregnancy because the 
proposed study required nicotine administration and nicotine products present well-known risks 
to developing fetuses.   
A demographic and health related information questionnaire was then administered to 
obtain demographic information for the purposes of describing the study sample and to verify 
inclusion criteria.  Variables assessed included age, race, socioeconomic status, employment, 
education, marital status, height, weight, health status, current medications and drug use history.  
The participant was then administered the SCID (First et al., 1994) by a trained clinician to 
screen for psychiatric conditions.  When study participation criteria were met, the participant was 
scheduled for 3 experimental sessions to occur no less than five days apart, beginning between 
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8:00 AM and 5:00 PM.  For each participant each session was scheduled at approximately the 
same start time (within two hours of other sessions). If the assessment session concluded 
between this time period, the participant was given the option to move immediately into the first 
experimental session.  Assessment sessions lasted approximately an hour and all participants 
were compensated at a rate of $20/hr regardless of whether study participation criteria were met. 
 Experimental Sessions 
Upon arrival to the facility, participants were required to submit two breath samples to 
ensure that breath carbon monoxide and breath alcohol content criteria were met.  Each 
experimental session began with the administration of gum delivering 2mg or 4mg nicotine, or 
placebo gum delivering no active substance (gum preparation and administration described 
below).   After dose administration, participants completed a series of self-report questionnaires 
which assessed their current physiological and emotional state.  Completion of these measures 
took approximately 10 minutes.  Research staff then administered a modified version of the 
human OST (adapted from Levy et al., 2003).  Because the present study sought to investigate 
performance of the OST as a primary aim, this task was the first cognitive task administered 
during each experimental session.  The human OST required about 40 minutes.  Following 
completion of the OST, research staff then administered the digit span, letter number sequencing, 
and the spatial span tasks of the WMS-III (Wechsler, 1997b) the rapid visual information 
processing task (RVIP) and the N-back task in a quasi-random order (three possible orderings).  
An example timeline of the experimental session is presented below (Figure 1).  After 
completion of the final cognitive task, participants were compensated for their time ($20/hr) and 
given an appointment card to serve as a reminder for their next appointment.  Each experimental 
session lasted approximately an hour and 45 minutes. 
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Figure 1.  A timeline of experimental sessions.  All values are expressed in minutes.  
 
Nicotine Administration 
 Nicotine and placebo gum were prepared daily by the experimenter and provided to 
research staff, who were blind to the dose received.  A placebo procedure described by 
Kleykamp et al. (2005) was used to prevent the detection of active doses through differences in 
odor, texture, taste and sensation between nicotine and placebo gum.  Nicotine gum (Nicorette® 
Freshmint™, Pfizer Health AB, Helsingborg, Sweden) or a similar dragée style gum (Dentyne 
Ice® Peppermint, Kraft Foods Inc., Northfields, Illinois) was wrapped with Wrigley’s sugar-free 
peppermint gum and received two drops (0.1 mL) of Tabasco sauce.  To ensure consistent 
chewing patterns across participants, a procedure was used in which the participant was 
prompted to chew their gum for 15 minutes at 3 second intervals by a computer generated tone 
(as in Houtsmuller, Fant, Eissenberg, Henningfield, & Stitzer, 2002; Kleykamp et al., 2005; 
Nemeth-Coslett & Henningfield, 1986).   
Compliance to the chewing procedure was monitored by research staff.  This dosing 
procedure has been demonstrated to produce peak blood plasma levels of 4.6 ng/mL for the 2 mg 
dose and 8.5 ng/ml for the 4mg dose (Hindmarch, Kerr, & Sherwood, 1990).  Time to peak blood 
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plasma concentration (Tmax) after chewing nicotine gum has been estimated at about 45 minutes 
to 1 hour for the 2mg and 4mg doses and plasma concentrations remain substantially elevated 
(approximately 75% of peak plasma) at 180 minutes  (Dautzenberg, Nides, Kienzler, & Callens, 
2007; Shiffman et al., 2009).  Thus a single administration should have been sufficient to sustain 
nicotine levels for the duration of experimental sessions. 
Measures 
 Current State Measures 
Wisconsin Smoking Withdrawal Scale (WSWS).  The WSWS (Welsch et al., 1999) 
concentration subscale was completed to provide a self-report measure of attention and 
concentration.  This measure supplemented objective experimental measures of attention and 
working memory. 
Positive Affect and Negative Affect Scale (PANAS).  The 20-item PANAS (Watson, 
Clark, & Tellegen, 1988) was completed after nicotine administration during each experimental 
session to assess current affective state.  The PANAS was scored to produce positive affect and 
negative affect scales which are internally reliable, and have been extensively validated (Watson, 
Wiese, Vaidya, & Tellegen, 1999).   
Feeling State Questionnaire (FSQ).  Six items from the FSQ (D. G. Gilbert et al., 2008) 
(irritable, attentive, jittery, nauseous, sick, and dizzy) were administered to assess effects of 
nicotine commonly reported by non-smokers. 
Working Memory and Attention Tasks 
The OST and clinical assessments were administered to participants in an experimental 
session room by trained members of the research team. All three of the clinical assessments were 
administered according to the protocol specified by the WMS-III administration and scoring 
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manual (Psychological Corporation, 2002).  The N-back and RVIP task were completed on a 
personal computer in the session room running E-prime software (Psychology Software Tools, 
Inc.).   
Olfactory Span Task (OST).  The OST used in the present study was adapted from 
procedures used by Levy et al. (2003) and was consistent with the olfactory span task originally 
developed for rats (Dudchenko et al., 2000). The task was administered using 22 household 
spices (High Quality Organics; Reno, NV). Spices were individually stored and presented in 
opaque plastic test tubes (Lake Charles Manufacturing; Lake Charles, LA) with plastic stoppers. 
Each test tube was approximately 1/3 filled with ground spice. Prior to the first experimental 
session, participants were randomly assigned to a set of 2 performance control odors which 
would remain constant across all three sessions and 1 of 3 orders in which the 3 stimulus sets of 
20 odors used in the odor span task would be presented across sessions. Each stimulus set was 
constructed with the constraint that no stimulus could serve as a comparison more than 3 times 
during the task. 
The task began with the experimenter introducing the participant to the performance 
control stimuli. A test tube rack holding the two performance control test tubes was placed on the 
table in front of the participant. The participant was instructed to sample both of the odors from 
left to right by removing the rubber stopper, placing their nose approximately one inch above the 
test tube, and breathing in gently before replacing the rubber stopper and moving to the next 
stimuli. After the participant sampled the second stimuli, the experimenter instructed the 
participant to remember the last odor they had sampled. The experimenter then reordered the 
control stimuli behind a cardboard shield. The stimuli were presented again and the participant 
was asked to sample the stimuli and indicate which tube contained the target odor. Participants 
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were given feedback on each choice. The performance control stimuli were reordered and 
presented for ten consecutive trials. The performance control procedure was conducted to ensure 
that participants were able to adequately discriminate between odorants during testing.  
Next the experimenter instructed the participant that on each new trial they would be 
asked to either identify the odor they were asked to remember or to identify an odor that they had 
not yet sampled. Each session contained 20 trials in which they were to detect the novel odor 
(span component) and 4 trials in which they were to identify their performance control odor. The 
span component began with the presentation of a single odor from the experimental odor set. The 
participant was asked to sample the odor and report whether they had sampled this odor during 
the session. This stimulus was then moved to a random position on the test tube rack and a 
second (novel) odor was added to the rack. The participant was then instructed to sample both 
odors and to report which odor was new. On each subsequent trial, a novel odor was presented 
with a comparison odor chosen quasi-randomly from odors that were presented as novel samples 
in previous trials.  
After every fourth trial of the OST, the performance control odors were presented and the 
participant was asked to report which odor they had been asked to remember at the beginning of 
the session. This was done to determine whether odor discrimination and motivation to perform 
had been maintained across trials of the session. For each trial, the experimenter recorded each 
response as a hit, or a false alarm, and overall performance was reported in terms of span, longest 
span and percent correct accuracy. Accuracy within each session was computed for each 
participant for both the span component and the performance control component. Accuracy at 
each span length (memory load) was computed by averaging accuracy at each span length (trial 
number) across participants.  
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Digit Span.   To administer the digit span task, the experimenter read strings of digits to 
the participant at a rate of 1 digit per second and the participant was instructed to repeat the 
string of digits back to the experimenter.  Administration included a digit forward component, 
where participants were instructed to repeat each string in the order presented by the 
experimenter, and a digit backward component where strings were to be repeated in reverse 
order.  Digit string lengths incremented from 2 to 9 digits during the course of the digit forward 
component, and from 2 to 8 digits during the digit backward component.  Participants were given 
2 trials at each string length in both the forward and backward components, and each component 
was discontinued when the participant failed both trials of a digit string length.  Measures 
derived from digit span performance included the number of correct trials within each 
component, longest string recited in each component, and total correct trials. The digit span task 
has sound psychometric properties including good test-retest reliability (R = .83) across 
approximately one month for individuals within the age range of the present study 
(Psychological Corporation, 2002).   
Spatial Span.  The spatial span task was administered in a manner analogous to the digit 
span with the exception that instead of verbally presenting strings of digits, the experimenter 
sequentially pointed to blocks which were identical in appearance but were located on discrete 
spatial positions of a board.  Participants were then required to reiterate the string of spatial 
locations by sequentially pointing to each block in the string.  As in the digit span task, the 
spatial span task included both a forward and backward component during which string lengths 
incremented with two trials at each string length.  
As with digit span, spatial span yielded measures including the number of correct trials in 
each component (forward and backward), the longest string length completed in each 
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component, and total correct trials.  The spatial span has sound psychometric properties and good 
test-retest reliability (R = .72) across approximately one month (Psychological Corporation, 
2002).   
Letter-number Sequencing.  To administer the letter-number sequencing task, the 
experimenter read strings of digits and letters to the participant who was instructed to repeat the 
numbers first in ascending order, followed by the letters in alphabetical order.  String lengths 
incremented from 2 to 9 digits and letters across the course of the task with 2 trials at each string 
length.  The task was discontinued when the participant failed to correctly recite two consecutive 
strings of the same length. The primary outcome measures were total correct trials and the 
longest letter-number sequence recited correctly.  The letter-number sequencing task has sound 
psychometric properties and good test-retest reliability (R = .71) across approximately one 
month (Psychological Corporation, 2002).   
N-back (0-back and 2-back).  The N-back task is a computerized assessment of working 
memory designed to assess performance across increasing memory loads.  Participants were 
presented with sequences of uppercase letters on a computer screen and were required to respond 
to each stimulus according instructions specific to each component of the task.  During the 0-
back (non-mnemonic) component of the task, participants were instructed to press the leftmost 
button of the response box when the presented stimulus matched a pre-specified target stimulus 
(i.e., an “X”) and to press the rightmost button of the response box when the presented stimulus 
was any other letter than the target.   
During the 2-back (mnemonic) component, participants were instructed to press the 
leftmost button of the response box when the presented stimulus matched the stimulus that had 
been presented 2 stimuli prior, and to press the rightmost button when the stimulus did not 
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match.  Participants were instructed to keep both of their hands on the response box for the 
duration of the task and to enter responses as quickly as possible with their corresponding index 
finger (left or right).  Practice trials were administered to verify understanding the task prior to 
performing each of the N-back components, which were administered in a fixed order (0-back 
then 2-back).   
There were a total 180 trials for each component (0-back and 2-back) divided into three 
blocks of 60 trials.  The 180 trials for each component included 54 targets and 126 non-targets, 
equally distributed across the three blocks in that condition.  The stimuli were presented one at a 
time in the center of the monitor for 250 milliseconds with an intertrial interval of 2 seconds.  
Each of ten uppercase letters (height = 3 cm) were presented on 10% of trials, or 18 times per 
condition (6 times per block).   
 Rapid Visual Information Processing Task (RVIP). The RVIP (Wesnes & Warburton, 
1983) is a neurocognitive measure of sustained attention/vigilance. Participants were presented 
with a string of digits on computer monitor at a rate of 100 digits per minute and were instructed 
to respond by pressing the leftmost button of a response box when three consecutive even or odd 
digits were presented. Eight target stimuli appeared during each minute, separated by between 5 
and 30 foils. Participants were instructed to keep both of their hands on the response box for the 
duration of the task and to enter responses as quickly as possible with their left index finger.  
Responses within 1,500 milliseconds of a target were scored as a hit while all other responses 
were scored as a false alarm.  The task took approximately 4 minutes to complete and yielded 
measures of hits, false alarms, and hit reaction time. 
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Primary Data Analyses 
Two-way repeated measures analysis of variance (ANOVA) tests were conducted to test 
within-subject effects of nicotine dose by dose order on the performance of cognitive tasks and 
self-reported attentional control.  For the analysis of each task the threshold of significance        
(p < .05) was adjusted to account for the number of measures obtained from that task.  For 
variables in which the assumption of sphericity was violated a Greenhouse-Geiser correction was 
made to degrees of freedom.   
Significant main effects were explored post-hoc, using simple effects analysis with a 
Bonferroni correction for multiple comparisons. Digit span and spatial span each yielded four 
raw scores (total and longest span forward, total and longest span backwards) while letter-
number sequencing task yielded only total score and longest span. N-back and RVIP measures 
consisted of percent correct accuracy on target stimuli, and distractor (non-target) stimuli. 
Additionally, RVIP reaction time for hits and N-back reaction time to targets and distractors 
were computed.  Measures derived from performance of the OST included span (number of 
correct consecutive trials minus one), longest span (the longest string of consecutive correct 
choices at any point after the first trial) and accuracy, which was computed for both span and 
odor discrimination components.  
Validity of the OST was assessed in several ways. Bivariate correlation was used to 
determine whether human accuracy on the OST is capacity dependent as is observed in rats 
(MacQueen et al., 2011). To conduct this analysis, mean accuracy for each trial of the span 
component of the OST was computed across participants from data obtained during the placebo 
administration session. Accuracy of the OST was then submitted to a correlational analysis with 
the span length at which each estimate was determined. Capacity dependence was to be 
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identified by a significant negative correlation coefficient. Additionally, convergent validity of 
the OST with other measures of working memory and attention were assessed through a series of 
bivariate correlations in which relevant dependent variables derived from the cognitive measures 
were correlated with total session OST accuracy, span, longest span as well as odor 
discrimination training accuracy odor discrimination performance.  
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RESULTS 
 
Participant Characteristics 
 Thirty participants (14 male), ranging from 18 to 48 years of age (M=25.48, Std. Dev. = 
7.65), completed all three experimental sessions.  As presented in Table 1 (see page 27), two-
thirds of the sample identified as Caucasian, with the remainder identifying as African American, 
or Asian.  Nearly one third of the sample identified as Hispanic or Latino. One participant 
identifying as Hispanic or Latino did not report on race, and one participant identifying as 
African American did not report on ethnicity. All but one participant had completed high school 
and 90 percent of the sample had completed some college or earned a degree.  On average, 
participants had completed 14.97 years of education at the time of study enrollment.  
Subjective Effects of Nicotine 
 Feeling State Questionnaire (FSQ) 
 Responses to the six items of the FSQ were submitted to a mixed two-way analysis of 
variance (ANOVA) evaluating the effects of nicotine dose and the between subject factor of dose 
order.  As depicted in Figure 2, participants reported feeling significantly more nauseous 
[F(1.50,40.41) = 10.775, p = .001], sick [F(1.45,39.04) = 12.514, p < .001], and dizzy 
[F(1.52,41.02) = 21.358, p < .001] after receiving gum containing nicotine.  In each case, simple 
effects analysis revealed that subjective report of these sensations was significantly greater after 
receiving the high dose when compared with the low or placebo doses (bonferroni corrected       
p < .05).  The effect of nicotine trended toward significance with regard to reports of irritability 
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[F(2,54) = 3.476, p = .038], and attentiveness [F(2,54) = 4.178, p = .021], but did not reach the 
family-wise error adjusted significance threshold (p < .008).  No effect of nicotine was observed 
on reports of feeling “jittery” [F(2,54) = 1.620, p = .207].  No effects of dose order, or nicotine 
dose by dose order interactions were detected for any of the FSQ items (all ps > .05).   
 
Table 1. Demographic Characteristics 
 
    n % 
Gender     
  Male 16 53.3 
  Female 14 46.7 
Ethnicity     
  Hispanic or Latino 9 30.0 
  Not Hispanic of Latino 20 66.7 
  Not reported 1 3.3 
Race     
  Caucasian 20 66.7 
  African American 7 23.3 
  Asian 2 6.7 
  Not reported 1 3.3 
Education Level     
  Some High School 1 3.3 
  Completed High School 2 6.7 
  Some College 20 66.7 
  Completed College 4 13.3 
  Some Graduate Work 1 3.3 
  A Graduate Degree 2 6.7 
 
 
Positive Affect/Negative Affect Scale (PANAS) 
Review of PANAS responses revealed that a single participant failed to provide 
responses to the second column of PANAS items after receiving the high dose of nicotine gum.  
As a result, this participant was excluded from analyses of PANAS measures (which included 
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the remaining 29 participants for whom complete data was available).  Positive affect and 
negative affect scales derived from responses on the PANAS were submitted to a mixed two-way 
ANOVA of nicotine dose by dose order.  No effect of nicotine, dose order, or their interaction 
was detected with regard to positive affect (ps > .05).  For negative affect, the main effect of 
nicotine dose increasing negative affect trended towards significance [F(1.50,42.18) = 4.146, p = 
.033],  but did not reach the adjusted significance threshold (p < .025).  No effect was observed 
for dose order or its interaction with nicotine dose.   
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Figure 2.  Effects of nicotine dose on the Feeling State Questionnaire items.  Asterisks indicate a 
significant difference relative to placebo. 
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Wisconsin Smoking Withdrawal Scale 
As presented in Figure 3, nicotine dose produced significant effects on the endorsement 
of the three WSWS items, “my level of concentration is excellent” [F(2,54) = 6.233, p = .004], 
“it is hard to pay attention to things” [F(1.38,37.12) = 5.538, p = .015], and “It’s difficult to think 
clearly” [F(1.52,41.07) = 6.473, p = .007].  Simple effects analysis revealed that the high 
nicotine dose significantly reduced endorsement of excellent concentration, and significantly 
increased endorsement of difficulty thinking and paying attention relative to placebo (bonferroni 
adjusted ps < .05).  Dose order produced a significant effect on endorsement of difficulty 
thinking [F(2,27) = 4.853, p = .016], but not on endorsement of difficulty paying attention, or 
excellent concentration (ps > .05).  Participants assigned to receive the high nicotine dose during 
the first session (followed by placebo and then the low dose in subsequent sessions), reported 
significantly greater difficulty thinking when compared with participants who received the low 
dose followed by the high dose and placebo (bonferroni adjusted p < .05).  A nicotine dose by 
dose order interaction was not detected for any of the three WSWS items.   
Effects of nicotine on attention and working memory 
Odor Span Task 
 Two-way mixed ANOVAs of nicotine dose by dose order (3 orderings) revealed no 
significant main effect of dose or dose order on any of the odor span measures (Odor span 
accuracy, span, longest span, simple discrimination training, and simple discrimination 
performance; all p’s >.05).  Odor span performance collapsed across dose order conditions is  
illustrated in Figure 4 (see page 31).   
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Figure 3.  Effects of nicotine dose on selected Wisconsin Smoking Withdrawal Scale items.  
Asterisks indicate a significant difference relative to placebo. 
 
A nicotine dose x dose order interaction was detected for odor span accuracy [F(4,54) = 
2.967, p = .027], span [F(4,54) = 3.910, p = .007], and longest span [F(4,54) = 3.910, p = .007].  
However, the interaction observed with odor span accuracy did not meet the family-wise error 
adjusted significance threshold (p < .01).  Nicotine dose by dose order interactions for span and 
longest span were characterized with one-way ANOVAs of nicotine dose within each of the 
three dose order groups.  No effect of dose on span or longest span was detected which reached 
the family-wise error adjustment significance level (p < .01) in any of the three dose order 
groups on span or longest span.   
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Figure 4.  Effect of nicotine dose on odor span measures: A) Odor span and simple 
discrimination accuracy B) Span and longest span measures. 
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Digit Span 
 Two-way mixed ANOVAs of nicotine dose by dose order revealed no significant main 
effects of dose or dose order, and no significant interactions between these variables on digit 
span measures (forward, backward, total, longest forward span, and longest backward span; all 
ps > .05).  
Spatial Span 
 Nicotine dose by dose order ANOVAs revealed no significant main effects of either 
nicotine dose or dose order on spatial span measures (forward, backward, and total; ps > .05).  
However, significant nicotine dose by dose order interactions were detected on both the spatial 
span backward [F(4,54) = 3.812, p = .008], and total [F(4,54) = 4.302, p = .004] measures.  
Interactions were characterized with one-way repeated measures ANOVAs of nicotine dose for 
each dose order group.  These analyses revealed no significant effect of nicotine dose on spatial 
span backward within any of the three dose order groups (all ps > .05).  With regard to the spatial 
span total measure there was a significant effect of dose amongst participants assigned to receive 
the low dose, followed by the high dose and placebo in subsequent sessions [F(1,18) = 6.695, p = 
.007].  Simple effects analysis revealed that performance after receiving the low dose (but not 
high dose) was significantly reduced relative to placebo (bonferroni corrected p < .05).  No 
effects of nicotine dose were detected in the placebo first or high dose first dose order conditions.   
Letter-number sequencing (LNS) 
 Two-way mixed ANOVAs of nicotine dose by dose order revealed no significant main 
effects of dose or dose order, and no significant interactions between these variables on LNS 
total or longest sequence (ps > .05).  
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0-back 
 Nicotine dose by dose order analyses exposed no significant main effects of nicotine dose 
or dose order and no significant interaction between these variables on any of the 0-back 
measures (target accuracy, distractor accuracy, target reaction time and distractor reaction time, 
all ps > .05).   
2-back 
 Review of 2-back performance revealed that during a single session, one participant 
responded only to target stimuli and failed to respond to distractor stimuli.  As a result, this 
participant was excluded from analyses of 2-back performance.  Amongst the remaining 29 
participants who completed the 2-back task during all three experimental sessions, mixed two-
way ANOVAs of nicotine dose and dose order found no significant main effect of either variable 
on any 2-back performance measure (target accuracy, distractor accuracy, target response time, 
or distractor response time; all ps > .05).  However, significant nicotine dose by dose order 
interactions were detected for both the target reaction time [F(4,52) = 4.652, p = .003] and 
distractor reaction time [F(4,52) = 3.862, p = .008] measures. These interactions were 
characterized with one-way ANOVAs evaluating the effect of nicotine dose within each dose 
order condition.   
A significant effect of nicotine dose on target reaction time was detected for participants 
assigned to receive the high nicotine dose during the first session [F(2,18) = 5.788, p = .011].  
Participants within this group were significantly slower in responding to target stimuli after 
receiving the high dose gum relative to placebo (bonferroni adjusted p < .05).  No effect of 
nicotine dose on target reaction time was detected amongst participants in either of the other two 
dose order conditions.  With regard to distractor reaction time, a significant effect of nicotine 
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dose was detected amongst participants who received the placebo dose first [F(1.58,14.19) = 
7.941, p = .007].  Simple effects analysis revealed that participants within this group produced 
significantly reduced reaction time to distractor stimuli after receiving the high dose relative to 
placebo (bonferroni adjusted p < .05).  No effect of nicotine dose on distractor stimuli reaction 
time was detected for participants in either of the other two dose order conditions (ps > .05).     
Rapid Visual Information Processing (RVIP) 
Two-way mixed ANOVA of nicotine dose by dose order revealed a significant effect of 
nicotine dose on RVIP target accuracy [F(2,54) = 4.586, p = .014].  As presented in Figure 5, 
RVIP target accuracy was significantly greater after participants received the high dose nicotine 
gum when compared with placebo (bonferroni corrected p < .05).  No effect of dose order or a 
nicotine dose by dose order interaction was detected for any of the RVIP measures (target 
accuracy, false alarm rate, and hit reaction time; all ps > .05).  Nicotine dose produced no 
significant main effects on either RVIP false alarm rate or hit reaction time.   
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Figure 5.  Effects of nicotine dose on RVIP target accuracy.  Asterisks indicate a significant 
difference relative to placebo. 
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Validation of the Odor Span Task 
During the placebo gum session, two thirds of participants provided perfect performances 
(10/10 correct responses) during odor discrimination training (m = 9.37, std = 1.16).  During 
completion of the OST (after placebo), 80% provided perfect performance on all four odor 
discrimination trials (m = 86.67%, std = 26.86%) while a single participant failed to perform 
above chance.  Span ranged from 0 to 16 (m = 4.47, std = 3.53), longest span ranged from 3 to 16 
(m = 6.77, std = 2.91), and average accuracy was 76.67% (std = 12.34%) with a single 
participant failing to perform above chance.  To evaluate the effect of memory load on accuracy, 
accuracy was computed across participants at each trial number (span length/memory load).  As 
reported above, nicotine produced no significant effects on odor span accuracy.  As such, 
accuracy for all three sessions (placebo, low dose, and high dose) were averaged for each 
participant to produce a more reliable estimate of accuracy at each span length.   
A bivariate correlation analysis was then conducted to assess the relationship between 
accuracy and memory load.  Accuracy at trial 1 was excluded from this analysis as participants 
were only presented with a single odor during this trial and thus accuracy was 100%.  As 
depicted in Figure 6, a significant negative correlation (r = -.528, p < .05) was detected between 
accuracy and the number of odors to remember reflecting a capacity dependent effect on odor 
span accuracy.  Figure 6 depicts accuracy on the four odor discrimination trials, which were 
conducted after every 5th trial of the OST, collapsed across doses.  A bivariate correlation 
analysis was not appropriate for this data given the relatively few number of odor discrimination 
trials conducted during the OST.  However, as illustrated in Figure 7, a one-way repeated 
measures ANOVA of odor discrimination found no effect of trial number on accuracy, F(3,87) = 
.809, p > .05. 
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Bivariate correlations were also used assess the association between measures derived 
from the odor span task after receiving placebo gum.  An adjusted significance threshold of p < 
.005 was used to control for the number of associations considered (10).  As noted a single 
participant was found to perform below chance levels on odor discrimination and the odor span 
during the placebo gum session.  This same participant was also found to be an outlier (two 
standard deviations above or below the mean) on several other measures of performance (0-back 
target reaction time, 0-back distractor reaction time, 0-back hit rate, 0-back false alarms).  Given 
exceptionally poor performance on several variables, this participant was excluded from all 
correlational analyses so as not to inflate the significance of any observed relationships.  All 
correlational analyses were conducted with the remaining 29 participants. 
 
Figure 6.  Average accuracy on odor span trials collapsed across dose conditions. 
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Figure 7.  Average odor discrimination trial accuracy averaged across dose conditions. 
 
It was expected that measures intended to evaluate the mnemonic components of the OST 
(percent correct accuracy, span, and longest span) would be modestly to strongly related, while 
measures of olfactory discrimination (simple discrimination training and simple discrimination 
accuracy) would relate with each other but not mnemonic indexes. Consistent with these 
hypotheses, simple discrimination training and simple discrimination accuracy demonstrated a 
strong significant positive association (r = .714, p < .001).  The relationship between simple 
discrimination practice trials and span trended towards significance (r = .441, p = .017) but did 
not reach the adjusted significance threshold.  Neither simple discrimination training nor 
accuracy provided a significant association with any of the other mnemonic odor span measures 
(all ps > .05).  As presented in Table 2, each of the three mnemonic odor span indices 
demonstrated a significant association with the other two mnemonic measures (rs ranging from 
.565 - .711; all ps ≤ .001).   
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Table 2.  Correlations Between Odor Span Measures 
Measure       1 2 3 4 5
Training and Control Measures             
  1. Odor Discrimination Training -         
  2. Odor Discrimination Accuracy .714* -       
Mnemonic Measures               
  3. Percent Correct Accuracy   .353 .369† -     
  4. Span       .441† .254 .565* -   
  5. Longest Span     .181 .198 .711* .658* - 
† p < .05, * p < .005.  Adjusting for multiple comparisons within each odor span measure, 
associations meeting a threshold of p < .005 were deemed significant. 
 
Bivariate correlations were also used to assess the association between odor span 
measures and measures derived from other tasks of attention and working memory (e.g., digit 
span, spatial span, letter-number sequencing, RVIP, 0-back, and 2-back) after placebo gum 
administration.  As each odor span measure was compared with 21 measures derived from the 
alternative cognitive tasks, the threshold used to identify significant associations (p < .002) was 
determined by adjusting for the number of comparisons made with each odor span measure.  
Table 3 presents the strength of association of odor span performance with other cognitive 
measures.  As expected, neither of the simple olfactory discrimination measures derived from the 
odor span task (simple discrimination training and accuracy) produced a significant association 
with any of the measures from the 6 cognitive tasks (all ps > .05).   
As depicted in Figure 8, odor span accuracy demonstrated a moderate significant positive 
association with 0-back hit rate (r = .589, p = .001) .  Similar positive trends were observed 
between span and 0-back hit rate (r = .374, p = .046) and longest span and 0-back hit rate (r = 
.444, p = .016) though these effects did not reach the adjusted significance threshold.  Trends 
were also observed between longest span and 2-back hit rate (r = .414, p = .026).  Both span and 
OST accuracy produced trend level associations with 2-back target reaction time (r = .374, p = 
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.045 for both associations).  The span measure additionally showed a trend level positive 
association with 2-back distractor reaction time (r = .396, p = .033) however, none of the 
relationships between span or longest span and the N-back measures reached the adjusted 
significance threshold.   
 
Table 3.  Correlations between odor span and cognitive measures 
      SD Practice  SD Accuracy  Span  Longest Span  OS Accuracy 
Digit Span                
   Forward  ‐.247  ‐.060  ‐.103  .225  ‐.239 
   Backward  .031  .156  .154  .306  .128 
   Total  ‐.136  .042  .014  .292  ‐.082 
   Longest Forward  ‐.075  .104  ‐.190  .001  ‐.322 
   Longest Backward  .084  .149  .203  .354  .240 
Spatial Span                
   Forward  ‐.156  ‐.050  ‐.165  ‐.051  ‐.297 
   Backward  .028  ‐.111  ‐.066  .041  .024 
   Total  ‐.083  ‐.096  ‐.151  ‐.021  ‐.156 
Letter‐Number Sequencing                
   Longest Sequence  .045  .177  .005  .098  .051 
   Total  ‐.292  ‐.130  ‐.125  .205  ‐.066 
0‐Back                
   Hit Rate  .070  .146  .374†  .444†  .589* 
   False Alarm Rate  ‐.137  ‐.230  ‐.262  ‐.328  ‐.317 
   Target Reaction Time  ‐.042  .056  ‐.245  .313  .167 
   Distractor Reaction Time  ‐.099  .027  ‐.259  .281  .157 
2‐Back                
   Hit Rate  ‐.231  ‐.010  .086  .414†  .337 
   False Alarm Rate  .253  .085  .045  ‐.344  ‐.149 
   Target Reaction Time  .179  .171  .374†  .313  .374† 
   Distractor Reaction Time  .144  .116  .396†  .281  .294 
RVIP                
   Hit Rate  .002  .147  ‐.047  .067  .242 
   False Alarm Rate  ‐.045  .154  ‐.111  ‐.172  ‐.129 
   Hit Reaction Time  .202  .203  ‐.029  ‐.159  ‐.122 
† p < .05, * p < .002.  Adjusting for multiple comparisons within each odor span measure, 
associations meeting a threshold of p < .002 were deemed statistically significant.
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Figure 8.   Relationship between OST accuracy and 0-back hit rate during placebo sessions. 
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DISCUSSION 
 
 A primary goal of the present study was to assess the effects nicotine on cognition, as it 
has been suggested that cognitive enhancement may be amongst the factors which motivate and 
reinforce tobacco smoking (Evans & Drobes, 2009). Amongst non-smoking participants, 
nicotine dose-dependently improved RVIP accuracy, indicating direct enhancement of attention.  
This corroborates earlier findings of improvement of “fast hits” (hits occurring in ≤450 ms) on 
the RVIP task in non-smokers receiving subcutaneous injections of 0.3 and 0.6 mg of nicotine 
(Foulds et al., 1996) and a trend towards improved RVIP hits in non-smokers after nicotine 
delivered by an inhaler (File, Fluck, & Leahy, 2001).  Results of another recent study also 
confirm improvement in RVIP accuracy after administration of nicotine gum (4mg) in non-
smokers (Knott et al., 2011).  However, in contrast with Foulds et al. (1996) and Knott et al., 
(2011) significant reductions in RVIP hit reaction time were not detected presently.  
 The RVIP is a target detection task which has been described as a measure of sustained 
attention or vigilance (Wesnes & Warburton, 1983).  Sustained attention refers to behavioral 
performance in detecting stimulus events which occur infrequently and unpredictably over 
extended periods of time (Sarter, Givens, & Bruno, 2001).  In addition to variants of the RVIP,  
alternative continuous performance tasks have been used to assess the effects of nicotine on 
sustained attention, revealing robust enhancements amongst smokers in deprivation and more 
limited evidence of enhancement in non-smokers (Heishman et al., 2010; Heishman et al., 1994).  
Performance on sustained attention tasks is critically mediated by cholinergic projections 
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stemming from the basal forebrain which serve to alter the processing of sensory stimuli in 
distributed areas of cortex as part of a right hemisphere lateralized fronto-parietal network 
(Sarter et al., 2001).   It has been suggested that the effect of nicotine on sustained attention is 
produced primarily by augmentation of the basal forebrain cholinergic system, which is also 
influenced by manipulations of GABAergic and glutamatergic signaling (Sarter et al., 2001).   
 Interestingly, the enhancement of RVIP performance reported presently occurred in the 
context of self-reported impairments in attention and concentration.  That participants reported 
increased difficulty paying attention and increased difficulty with thinking and concentration 
after receiving the high dose nicotine gum suggests that the enhancement of RVIP accuracy is 
not easily accounted for by participant expectancies regarding the cognitive effects of nicotine.  
Further, the lack of an effect of nicotine on RVIP reaction time counters the suggestion RVIP 
effects were produced by enhancement of sensorimotor abilities.  Analyses evaluating the 
interactive effect of nicotine dose with the order in which doses were received, produced no 
evidence that the effect of nicotine on RVIP performance was moderated by dose order.   
 The present study also included other measures which have been suggested to index 
aspects of attention, most notably the 0-back component of the N-back task.  The 0-back is 
essentially a target identification task, requiring participants to respond “yes” or “no” as to 
whether each stimulus that is presented matches a predefined target.  In contrast to the RVIP, 
which requires participants to respond only when three even or odd digits are presented in a row 
(thus accurate responding requires continuously updated memory of the last two stimuli 
presented), the 0-back task has no mnemonic demand.  As such, one might expect more 
pronounced effects on the 0-back (when compared with the RVIP) if the cognitive effects of 
nicotine are primarily constrained to attentional processes.  However, several factors need to be 
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considered when interpreting the observed enhancement of RVIP in the absence of effects on 0-
back accuracy.  In the present study, RVIP hit rate (target accuracy) was approximately 43% 
(median = 42%) during sessions in which participants received placebo gum, compared with 
approximately 93% (median = 95%) for 0-back hit rate.  As such, a ceiling effect may have 
limited the ability to observe an enhancement effect of nicotine on 0-back accuracy.  Although 
the 0-back task required attention to be sustained over a longer period of time (nearly 7 minutes 
compared with 4 minutes for RVIP), the speed at which stimuli were presented (1 stimulus every 
600ms for RVIP compared with 2250ms for 0-back), and the infrequency with which a response 
was required (only after targets for RVIP compared with every trial for 0-back) are likely critical 
aspects of the RVIP which create greater demands upon sustained attention, yielding greater 
difficulty than 0-back. 
 Compared with the RVIP, the effect of nicotine on N-back accuracy has been studied 
more extensively in non-smokers, using a variety of methods for the administration of nicotine 
(See Heishman et al., 2010).  In a prior investigation which used an identical placebo controlled 
nicotine gum administration procedure with never-smokers, nicotine failed to produce effects on 
visualspatial, or phonological 2-back or 3-back accuracy (Kleykamp et al., 2005).  Across a 
range of delivery methods, nicotine generally has not produced significant effects in N-back 
accuracy amongst non-smokers (Heishman et al., 2010).  However, a notable exception is found 
in a study reported by Kumari et al. (2003) in which subcutaneous doses of nicotine (12 µg/kg 
body weight) were delivered to 11 male non-smokers who subsequently completed an N-back 
task (0-back, 1-back, 2-back, and 3-back) while undergoing functional magnetic resonance 
imaging (fMRI). Compared with performance after subcutaneous delivery of saline, nicotine 
improved accuracy across the N-back conditions tested.  Given that nicotine induced 
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enhancement of N-back accuracy has not typically been observed, even in studies with larger 
sample sizes (and presumably greater power to detect such effects), certain aspects of the 
methods used in this study are worth mentioning.     
 The Kumari et al. (2003) study utilized a modified version of the N-back task, previously 
described by Callicot et al. (1999), in which both visuospatial and visual/symbolic cues could be 
used in the service of accurate responding.  Only four digits were presented during the task (1-4) 
and each digit was only ever presented in a distinct spatial position (one of the four corners of the 
screen).  This contrasts with more typical procedures in which all stimuli are presented in the 
center of the screen.  Thus participants could respond based upon the spatial position of the 
stimulus, the phonological or symbolic content of the stimulus, or a combination of these factors.   
Additionally, instead of providing a yes/no match response, participants were required to respond 
to each stimulus by pressing the response button which was associated with the stimulus 
presented N positions back, depending on the component being tested (i.e., 0-back, 1-back, 2-
back or 3-back).   Either of these task modifications may have introduced additional 
neurocognitive demands which are more readily augmented by nicotine.   
The inclusion of a spatial element seems unlikely to be critical as a prior study which 
tested phonological and spatial N-back performance separately found no effect of nicotine on 
either task in never-smokers (Kleykamp et al., 2005)  and no effects of nicotine were found in 
the spatial working memory task (spatial span) included in the present study.  However, it 
remains conceivable that the ability to use a preferred cue or a combination of cue modalities 
influences the detection of nicotine effects in non-smokers.  In addition to the unique response 
requirement (identifying the stimulus which occurred N positions back), the N-back task used by 
Kumari, et al. (2003) also utilized a more rapid stimulus presentation than is typical for N-back 
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tasks (1 stimulus every 1750 ms).  Future investigations in which these parameters of the N-back 
task (cue modality, response requirement, and stimulus presentation rate) are explicitly 
manipulated may help clarify domains of cognitive performance enhanced by nicotine in non-
smokers. 
In the present study, no main effect of nicotine dose was detected on any of the measures 
derived from common clinical assessments of working memory (i.e., digit span, spatial span, and 
letter-number sequencing).  While these tasks receive widespread use in the clinical practice of 
neuropsychology, they have been less commonly used to evaluate to the cognitive effects of 
smoking/nicotine when compared with experimental/computerized tasks such as the RVIP and 
N-back.  In contrast with measures of sustained attention, abstinence amongst smokers has not 
been associated with impairments in digit span performance (Merritt, Cobb, & Cook, 2012; 
Merritt, Cobb, Moissinac, & Hirshman, 2010) and no evidence of nicotine-induced enhancement 
of digit span was detected in a study which included both smokers and non-smokers (Jones, 
Sahakian, Levy, Warburton, & Gray, 1992).  To our knowledge, the present study represents the 
first test of the effects of nicotine on the spatial span and letter number-sequencing tasks 
conducted in healthy non-smokers.  However, nicotine did not reliably enhance performance of 
either task. 
The findings reported presently are largely consistent with a meta-analysis of prior 
studies regarding the effects of nicotine on cognition in never-smokers, ex-smokers, and non-
deprived smokers (Heishman et al., 2010).  That is, we detected significant enhancement of 
sustained attention accuracy (as measured by RVIP performance), but no effects of nicotine on 
accuracy across a range of experimental and clinical measures of working memory.  The 
parameters of working memory remain hotly contested and the tasks which are used to assess 
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working memory performance in clinical settings, such as the Digit Span, Letter-Number 
Sequencing, Arithmetic, and Spatial Span subtests of the Wechsler intelligence and memory 
batteries (Wechsler, 1997a, 1997b), differ substantially from tasks more commonly used to 
assess this construct in cognitive research (i.e., N-back, Operation Span, Listening Span).   
A benefit of the Wechsler tests is that they are highly standardized and normative data is 
readily available.  However, it has been suggested that contemporary lab-based working memory 
tasks are more consistent with defining aspects of the working memory construct, have better 
predictive ability in discriminating clinical pathology, and are associated with similar 
neurobiological substrates (Shelton, Elliott, Hill, Calamia, & Gouvier, 2009).  Yet, there remains 
a dearth of information available on the relationship between clinical and experimental tasks of 
working memory. Further, the lack of standardization of experimental tasks complicates  
between study comparisons.  One study directly comparing the working memory subtests of the 
Wechsler batteries with experimental tasks (including a word recall variant of the N-back) 
reported significant but relatively modest associations (rs ranging from .23-.54) between clinical 
and experimental tasks (Shelton et al., 2009).  Thus, each task likely captures unique aspects of 
mnemonic performance that may depend in part on distinct neurocognitive processes.   
The odor span task may provide a useful model for comparing mnemonic performance 
across species and outlining the neurobiological substrates involved.   With regard to the present 
investigation of nicotine effects, human odor span performance was of particular interest in that 
manipulations of cholinergic signaling have been found to impact odor span performance in 
rodents (Rushforth et al., 2010; Turchi & Sarter, 2000; Young, Crawford, et al., 2007).   
However, no main effect of nicotine was detected on any of the measures derived from the 
human odor span task in the present study.  Significant interactions between nicotine dose and 
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dose order were detected for both the span and longest span measures however, follow-up 
analyses evaluating the effect of dose within each of the three dose order groups failed to 
uncover any significant effects of dose.  There was however, a trend for increased span at the 
high dose (p = .057) for those who received the low dose first (followed by the high dose and 
then placebo on subsequent sessions), and for increased span at the low dose (p = .084) for those 
who received the high dose first (followed by placebo, then the low dose).  Similarly, while no 
significant effects of dose were detected in either of the 3 groups with regard to longest span, 
there was a trend towards increased span at the high dose amongst participants who received the 
low dose during their first session (p = .088).  In each of these cases there was a trend towards 
increased span (or longest span) during the second session in which nicotine was administered, 
regardless of whether the participant received the low or high dose during the second nicotine 
session.   
Thus, it is conceivable that recent exposure to nicotine is necessary before enhancement 
of odor span performance can be detected in non-smokers.  While not conclusive, it is notable 
that the means for both span and longest span followed a pattern of dose dependent facilitation.  
A similar pattern was not observed with regard to overall odor span accuracy.  Nicotine effects 
on overall accuracy has yet to be assessed in rats.  A prior study of the effects of nicotine used a 
procedure in which the task was terminated after the first error was observed and thus, did not 
yield an overall accuracy measure (Rushforth et al., 2011).   
The human adaptation of the odor span task used presently built upon the methods 
described by Levy et al., (2003) by including control procedures previously implemented in the 
odor span for rats (MacQueen et al., 2011).  This included training subjects on an olfactory 
discrimination of two odors not used in the span procedure which was subsequently tested at four 
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points during completion of the odor span task.  As in rats, humans achieved higher accuracy on 
simple discrimination trials (86.7%) when compared with odor span trials (76.7%) after placebo 
and after both nicotine doses.  Odor span accuracy was somewhat lower than averages observed 
in healthy controls (90.6%) in the Levy et al. (2003) study.  However, this was somewhat 
expected as the present design included 20 odors whereas the previous design included only 14.  
The present study also observed lower mean span (4.47 after placebo) than has been previously 
reported.  Though, as has been observed in rats (April, Bruce, & Galizio, 2013; Galizio, Deal, 
Hawkey, & April, 2013; MacQueen et al., 2011), participants frequently responded with high 
rates of accuracy even after an initial error.  As such, longest span (the longest string of 
consecutive correct responses observed after trial 1) was considerably higher (6.77 after placebo) 
and more consistent with the span lengths typically reported for animals and in the prior human 
study.   
In the original version of the OST for rats, and in the prior human odor span study, the 
number of odors to be remembered on any given trial was inherently confounded with the 
number of stimuli presented, and thus chance performance, during that trial.  In rats, accuracy 
has been shown to decrease as the number of comparison stimuli presented is increased (April et 
al., 2013).  This observation complicates evaluation of the association between memory load and 
performance in designs in which the number of comparisons increments across trials.  In the 
present study, this issue was avoided by presenting no more than two stimuli (one novel odor and 
one comparison) on any given trial.  As a result, chance performance was equated across all trials 
beyond the first at 50%.  As is observed with rats, a negative association between accuracy and 
the number of odors to be remembered was detected in our human participants.  A similar trend 
was not observed across odor discrimination trials conducted after every fifth OST trial 
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suggesting that declining accuracy is not easily accounted for by fatigue or progressive 
impairments in odor discrimination or task motivation.  However, it should be noted that with an 
OST procedure that limits the number of comparison stimuli presented on any given trial there 
remains a potential confound between memory load and delay.  That is, as the task progresses the 
comparison (non-target) odor that is selected for any trial may be more temporally distant from 
the initial presentation of that odor as a target than on earlier trials. An advantage of the two 
choice odor span procedure described previously in rats (April et al., 2013) and used presently in 
human non-smokers, is that it could facilitate designs in which variations of delay are 
systematically programmed in addition to capacity (memory load), allowing for a concurrent 
evaluation of both variables across species.    
 Though odor span performance appears to be capacity dependent in both humans and 
rats, the task likely does not index a limited capacity memory process of the kind proposed in 
contemporary models of human working memory.  As noted in rats (see April et al., 2013) and 
observed presently in humans, performance does not fail entirely after initial production of errors 
as is observed in human span tasks such as the digit span or spatial span tasks.   Our data with 
non-smokers found accuracy to be well above chance at the highest memory load tested (19 
odors to be remembered) and rats have performed above chance at a memory load of at least 71 
odors (April et al., 2013).  A capacity limit for either species has yet to be identified.  As such, it 
has been suggested that odor span may assess function of a near limitless form of recognition 
memory akin to picture recognition in humans (April et al., 2013).   
To evaluate the relevance of the OST to human cognition, the present study evaluated the 
relationship between the measures derived from the OST as well as their associations with well 
accepted measures of attention and working memory.  As expected, the odor discrimination 
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training and performance measures were strongly correlated with each other but showed no 
significant correlation with odor span, longest span, or overall accuracy.  Further, simple odor 
discrimination measures did not correlate significantly with any other measure of human 
attention or working memory.   
In contrast, significant relationships were detected between odor span measures and those 
derived from the N-back task.  Most notably, moderate positive correlations were detected 
between 0-back hit rate and the span, longest span, and overall accuracy measures (rs ranging 
from .374-.589).  Overall accuracy showed the strongest association with 0-back hit rate which 
remained significant after correcting for multiple comparisons.  Positive correlations were also 
detected between each of the odor span measures and aspects of 2-back performance.  However, 
these relationships were mostly constrained to 2-back reaction time and also did not reach the 
corrected significance threshold.  In general, odor span performance appears to be most related to 
0-back performance, somewhat associated with 2-back performance, and demonstrated no 
relationship with other span tasks.   Thus, the present data lends support to the suggestion that 
the odor span task is not a model for the form of limited capacity short-term memory assessed by 
human working memory tasks.   
The relationship between odor span accuracy and hit rate on a visual/symbolic N-back 
task is intriguing as it suggests that odor span measures may index neurocognitive processes of 
attention and recognition which are shared across tasks that utilize disparate stimulus modalities.  
Several psychiatric conditions are characterized by inattention, as evidenced by deficits in N-
back performance, including ADHD (Karatekin, Bingham, & White, 2009; Klein, Wendling, 
Huettner, Ruder, & Peper, 2006; Shallice et al., 2002) and schizophrenia/psychosis (Haatveit et 
al., 2010; Jansma, Ramsey, van der Wee, & Kahn, 2004; Karatekin et al., 2009).  While these 
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conditions are also associated with deficits in working memory, it has been suggested that 
inattention may underlie the deficits observed in these groups on more complex working 
memory tasks (Karatekin et al., 2009).   
The OST has been acknowledged as a promising tool for investigating cognitive effects 
in preclinical models of schizophrenia (Dudchenko, Talpos, Young, & Baxter, 2013) and the 
present study lends credibility to the translational merits of the task. While other tasks of 
attention and recognition have been modeled for animals based on procedures used in humans 
(i.e. go/no-go tasks, serial response tasks), the OST variant described presently is somewhat 
unique in that it includes control procedures for concurrently assessing effects on stimulus 
discrimination, and could be used to evaluate both capacity and delay effects within the same 
task.  The availability of a validated task which utilizes olfactory stimuli also provides a means 
by which the shared and distinct neurocognitive processes involved in attention and recognition 
tasks can be assessed across stimulus/sensory modalities.  Further, the odor span task may be 
particularly useful for evaluating the neurocognitive pathology of conditions which have been 
associated with abnormalities or changes in olfaction such as Alzheimer’s disease (Devanand et 
al., 2000; P. E. Gilbert, Barr, & Murphy, 2004; P. E. Gilbert & Murphy, 2004a, 2004b) and 
PTSD (Croy, Schellong, Joraschky, & Hummel, 2010; Dileo, Brewer, Hopwood, Anderson, & 
Creamer, 2008).               
It is somewhat surprising that nicotine effects were not observed on the OST given the 
preclinical literature suggesting cholinergic involvement in odor span performance and nicotine 
induced enhancement of performance (Rushforth et al., 2010; Rushforth et al., 2011; Turchi & 
Sarter, 2000; Young, Crawford, et al., 2007; Young, Kerr, et al., 2007).  However, nicotine also 
did not enhance N-back performance as has been previously reported in human non-smokers 
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(Kumari et al., 2003).  In sum, the results of the present study are largely consistent with meta-
analyses of nicotine effects in non-smokers/ex-smokers in that nicotine enhanced sustained 
attention (as indexed by RVIP performance) but produced no effects on alternative measures of 
attention and working memory.  A strength of the present study was that the sample was 
constrained to participants who had a very limited history of nicotine use (less than 6 lifetime 
uses of nicotine products).  However, it is plausible that this inclusion criteria biased the sample 
towards individuals who experience only limited positive effects of nicotine or are especially 
sensitive to the aversive effects of nicotine.   
Participants did indeed report dose dependent increases in aversive nicotine effects which 
may have counteracted any cognitive enhancing effects of the drug.  Recent nicotine use may be 
important for allaying these aversive effects and thus for detecting cognitive effects in non-
dependent individuals.  In the present sample, trend level effects suggested that enhancement of 
odor span performance was more likely after the second administration of nicotine regardless of 
whether the high dose or lose dose was delivered.  Future studies may avoid sampling 
individuals who have opted out of initiating regular smoking as a result of their individual 
reaction to nicotine by restricting their sample to younger participants.  Additionally, recruiting 
non-dependent individuals who have had multiple recent exposures to nicotine, or providing 
nicotine exposure prior to testing, may reduce the occurrence of aversive nicotine effects which 
could counter beneficial cognitive effects. 
It is also worth noting that the present sample was screened for medical and psychiatric 
conditions, as well as substance use.  This was done for participant safety and to avoid potential 
confounding cognitive effects of these variables.  However, this also serves to limit 
generalizability of the findings to non-smokers who are free of the aforementioned conditions.  It 
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has been suggested that the cognitive enhancing effects of nicotine may be more pronounced in, 
or constrained to, individuals who have relative deficits in certain cognitive domains (Evans & 
Drobes, 2009).  To the extent that such deficits are associated with the excluded conditions or 
general functioning, the sample may also have been biased towards individuals less likely to 
demonstrate nicotine induced enhancement. As a whole the inclusion/exclusion criteria used in 
the present study allowed for timely recruitment of a non-smoking sample larger than is typical 
of experimental studies of nicotine and cognition (See Heishman et al., 2010).  This provided 
additional power for detecting subtle drug effects and allowed for an analysis of the potential 
moderating effects of dose-order.  However, dose order did interact with nicotine dose on the 
OST (span and longest span), spatial span (backward and total) and 2-back (target and distractor 
reaction time) performance.   
Detrimental effects of the first nicotine dose administered were detected on spatial span 
for those who received the low dose first and on 2-back target reaction time for those who 
received the high dose first, while those who received placebo first subsequently showed 
enhancement of 2-back distractor reaction during the second nicotine administration (high dose).  
Though not conclusive, considered alongside the dose order effects for odor span this pattern 
suggests that initial exposures to nicotine may impair performance while subsequent exposures 
provide enhancement.  This highlights the need to counterbalance dose orderings in drug studies 
which use a repeated measures design (a strength of the present study).  Another strength of the 
study was the use of a double-blind testing procedure in which the experimenter was blind to 
which dose the participant received and the participant was informed only that they may receive 
nicotine during the study.  This served to limit the possibility of drug expectancies influencing 
participant performance and/or experimenter bias. 
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The present study was successful in further validating the placebo controlled nicotine 
gum administration procedure used previously by Kleykamp et al. (2005) to deliver nicotine to 
never-smokers.  As in the Kleykamp et al. study, nicotine delivered in this manner produced 
significant effects on multiple subjective report measures evaluating common negative side-
effects of nicotine (i.e., nausea, sickness, and dizziness).  While significant effects in these 
domains were only detected after administration of the high dose (4mg) of nicotine gum, average 
ratings for each item followed a dose-dependent pattern suggesting that a lesser level of nicotine 
was delivered through administration of the low dose (2mg) gum.  Though administration of 
high dose nicotine gum produced a range of aversive effects in never-smokers, it is also worth 
noting that these effects were generally reported as mild to moderate.  Thus, the present study 
lends further support to the use of the placebo controlled gum procedure as a safe and effective 
method for administering nicotine to never-smokers.   
While the randomized, double-blind, placebo controlled, counterbalanced, repeated 
measures design provided many strengths, there remains several limitations worth noting.  
Though the placebo controlled nicotine gum administration procedure provided a safe, non-
invasive, and well validated means by which to administer nicotine to non-smokers there is 
likely considerable variability in the dose delivered to individual participants through this 
method.  As in Kleykamp et al. (2005), a standardized chewing procedure was implemented to 
reduce variability; however, no biological measure was collected to quantify the dose delivered 
to participants after administration.  Assessment of plasma nicotine levels would have allowed 
for a more precise analysis of nicotine effects on cognitive performance.  However, this measure 
was not obtained due to concerns regarding the invasiveness of collection, participant reactivity 
to the procedure, as well as cost and time constraints.  Other limitations stem from the use of the 
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repeated measures design.  Though repeated testing can enhance statistical power by controlling 
for between subject variance it also introduces the potential for practice effects as participants 
completed each task repeatedly.  On average, experimental sessions were spaced approximately 
9 days apart (no less than 6 days for any participant).  However, it remains conceivable that an 
initial exposure to these tasks could significantly improve performance during subsequent 
testing.  This may be particularly relevant for the non-clinical tasks (odor span, RVIP, and N-
back) for which normative test-retest data are not available.   
In sum, the present study provides further validation for a placebo controlled nicotine 
gum administration procedure for never-smokers and evidence of dose dependent enhancement 
of sustained attention amongst this group.  Effects on sustained attention were detected despite 
dose dependent impairments in self-reported attention and concentration.  Indications of broader 
cognitive enhancement were obtained amongst participants during their second experimental 
exposure to nicotine.  Additionally, the odor span task was successfully adapted for humans with 
the inclusion of control procedures described in preclinical studies.  Human odor span 
performance demonstrated capacity effects, as are observed in rats, and was positively associated 
with accuracy on a visual/symbolic 0-back task.  Thus, the odor span task may be best 
conceptualized as an attention or recognition memory task which is sensitive to capacity effects. 
As such, it may be particularly useful in preclinical models of disorders characterized by 
impaired attention or selective olfactory deficits. 
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